COMMUNIQUÉS West-GlobeNewswire

Voting Rights and Shares Capital of the Company

12/02/2025 - 22:15

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Feb. 12, 2025 (GLOBE NEWSWIRE [...]

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

12/02/2025 - 22:15

DOVER, Del., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced [...]

Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit

12/02/2025 - 22:30

VANCOUVER, British Columbia and SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today [...]

Illuccix® Approved in the United Kingdom

12/02/2025 - 22:38

MELBOURNE, Australia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory [...]

Idorsia publishes the resolutions for the upcoming bondholder meeting

12/02/2025 - 23:00

Ad hoc announcement pursuant to Art. 53 LR The updated invitation to the bondholder meeting – scheduled for February 25, 2025 – sets out the terms of the resolutions to be voted upon Unaudited Financial Status as of [...]

Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland

11/02/2025 - 15:00

SOLANA BEACH, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]

Granite Recovery Centers Renames Residential Mental Health Treatment Facility

11/02/2025 - 15:00

New Freedom Academy is now Canterbury Behavioral Health CANTERBURY, N.H., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Granite Recovery Centers is pleased to announce a name change for one of its key mental health treatment [...]

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

11/02/2025 - 15:00

UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/ approvals in the U.S., Europe, Canada and Israel ATLANTA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical [...]

LogicMark Launches Next Generation of Guardian Alert 911 Plus Technology

11/02/2025 - 15:00

Best-selling personal emergency response device is newly enhanced with fall detection, and a modern, sleek design LOUISVILLE, Ky., Feb. 11, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK) (the “Company”), a [...]

United Theranostics Secures $15 Million Senior Debt Facility to Fuel Network Growth and Expansion

11/02/2025 - 15:00

Minneapolis, MN, Feb. 11, 2025 (GLOBE NEWSWIRE) -- United Theranostics, a leading provider of radiopharmaceutical therapy and supportive molecular imaging for cancer treatment, is pleased to announce it successfully [...]

First Stop Health Names New Chief Marketing Officer and Chief Technology Officer

11/02/2025 - 15:00

On-demand virtual care company expands leadership bench with seasoned healthcare technology leader Vijay Anand and longtime growth and marketing executive Will Setliff CHICAGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- First [...]

Solera Health Bolsters Executive Ranks with Several Seasoned Healthcare Leaders

11/02/2025 - 15:00

Four CXOs expand the company’s senior leadership team ahead of technology expansion PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Solera Health , the premier technology platform creating a bespoke digital health solution [...]

Aligned Marketplace Selects CirrusMD to National Advanced Primary Care Marketplace

11/02/2025 - 15:00

Employees can now select CirrusMD as their virtual primary care provider, connecting them to always-on, immediate, accessible, high-quality care DENVER, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CirrusMD, creator of the [...]

St. Joe’s Emergency Department Transformation Now Complete

11/02/2025 - 15:00

West end Toronto emergency department is 40% larger, fully donor-funded TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- St. Joseph’s Health Centre Foundation announced today that it has completed the transformation of its [...]

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease

11/02/2025 - 15:15

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]

BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM

11/02/2025 - 15:21

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in any Phase 3 study of ATTR-CM to date In as few as 3 months, the time to [...]

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program

11/02/2025 - 15:25

Significant Efficacy and No Serious Adverse Effects Observed with CELZ-201 PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company [...]

Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic Insights

11/02/2025 - 16:00

10-years of translating scientific innovation into accessible clinical solutions HOUSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic laboratory at the forefront of genetic testing, marks [...]

Cepham Introduces Life Phases and Stages Blends For the Next Evolution in Personalized Nutrition

11/02/2025 - 16:00

SOMERSET, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Cepham , a leader in nutraceutical innovation, has introduced its Life Phases and Stages Blends (LPAS Blends), a new line of scientifically formulated ingredient blends [...]